{"id":314023,"date":"2026-10-16T15:00:58","date_gmt":"2026-10-16T09:30:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=314023"},"modified":"2026-10-16T15:00:58","modified_gmt":"2026-10-16T09:30:58","slug":"formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/","title":{"rendered":"3 Formulations and API Major, Surface Treatment Chemical and Fortune Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Grauer &#038; Weil (India) and AWL Agri Business"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Aurobindo Pharma Rs 1,677.90, P\/E 25.46. Grauer &amp; Weil Rs 79.04, P\/E 22.12. AWL Agri Rs 190.54, P\/E 20.49. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Formulations and API major, surface treatment chemical and Fortune brand stocks with the clearest long-term roadmaps today include Aurobindo Pharma in generic formulations and active ingredients sold in the US, Europe and emerging markets, Grauer &amp; Weil in surface treatment chemicals and related industrial products and AWL Agri in edible oils, packaged foods and staples sold under the Fortune brand. FY26 revenue growth was 5.6% at Aurobindo Pharma, 5.1% at Grauer &amp; Weil and 17.6% at AWL Agri. P\/E stands at 25.46 for Aurobindo Pharma (industry 37.59), 22.12 for Grauer &amp; Weil (industry 36.60) and 20.49 for AWL Agri (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Formulations and API major, surface treatment chemical and Fortune brand stocks give investors exposure to medicines, industrial chemicals and kitchen staples sold at home and abroad. Volumes, export demand and margins decide how much of that demand turns into profit.<\/p>\n<p>Readers comparing formulations and API major, surface treatment chemical and Fortune brand stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.<\/p>\n<p>This list covers three formulations and API major, surface treatment chemical and Fortune brand stocks: Aurobindo Pharma for generic formulations and active ingredients sold in the US, Europe and emerging markets, Grauer &amp; Weil (India) for surface treatment chemicals and related industrial products and AWL Agri Business for edible oils, packaged foods and staples sold under the Fortune brand. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#What_Are_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\" title=\"What Are Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks?\">What Are Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_at_a_Glance\" title=\"Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks at a Glance\">Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Why_Do_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks Have a Strong Roadmap in India?\">Why Do Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Aurobindo_Pharma_Generic_Formulations_and_Ingredients_Build_the_Next_Leg\" title=\"Aurobindo Pharma: Generic Formulations and Ingredients Build the Next Leg\">Aurobindo Pharma: Generic Formulations and Ingredients Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\" title=\"Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline\">Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#AWL_Agri_Business_Edible_Oils_and_Staples_Build_the_Next_Leg\" title=\"AWL Agri Business: Edible Oils and Staples Build the Next Leg\">AWL Agri Business: Edible Oils and Staples Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Best_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_in_India_Aurobindo_Pharma_vs_Grauer_Weil_vs_AWL_Agri_on_Key_Financials\" title=\"Best Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks in India: Aurobindo Pharma vs Grauer &amp; Weil vs AWL Agri on Key Financials\">Best Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks in India: Aurobindo Pharma vs Grauer &amp; Weil vs AWL Agri on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#How_to_Evaluate_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks to Buy Before You Invest\">How to Evaluate Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Risks_to_Consider_Before_Investing_in_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\" title=\"Risks to Consider Before Investing in Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks\">Risks to Consider Before Investing in Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#FAQs_on_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\" title=\"FAQs on Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks\">FAQs on Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Which_are_the_best_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best formulations and API major, surface treatment chemical and Fortune brand stocks in India with a strong roadmap?\">Which are the best formulations and API major, surface treatment chemical and Fortune brand stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Is_Aurobindo_Pharma_a_good_stock_to_buy_now\" title=\"Is Aurobindo Pharma a good stock to buy now?\">Is Aurobindo Pharma a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#What_is_the_PE_ratio_of_Aurobindo_Pharma_Grauer_Weil_and_AWL_Agri\" title=\"What is the P\/E ratio of Aurobindo Pharma, Grauer &amp; Weil and AWL Agri?\">What is the P\/E ratio of Aurobindo Pharma, Grauer &amp; Weil and AWL Agri?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Which_of_these_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_has_the_highest_return_on_equity\" title=\"Which of these formulations and API major, surface treatment chemical and Fortune brand stocks has the highest return on equity?\">Which of these formulations and API major, surface treatment chemical and Fortune brand stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#What_are_the_risks_of_investing_in_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks\" title=\"What are the risks of investing in formulations and API major, surface treatment chemical and Fortune brand stocks?\">What are the risks of investing in formulations and API major, surface treatment chemical and Fortune brand stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#How_did_Aurobindo_Pharma_Grauer_Weil_and_AWL_Agri_perform_in_Q1_FY27\" title=\"How did Aurobindo Pharma, Grauer &amp; Weil and AWL Agri perform in Q1 FY27?\">How did Aurobindo Pharma, Grauer &amp; Weil and AWL Agri perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#Do_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_pay_dividends\" title=\"Do formulations and API major, surface treatment chemical and Fortune brand stocks pay dividends?\">Do formulations and API major, surface treatment chemical and Fortune brand stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks-roadmap-lookout-list\/#How_can_I_invest_in_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_in_India\" title=\"How can I invest in formulations and API major, surface treatment chemical and Fortune brand stocks in India?\">How can I invest in formulations and API major, surface treatment chemical and Fortune brand stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\"><\/span><strong>What Are Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Formulations and API major, surface treatment chemical and Fortune brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_at_a_Glance\"><\/span><strong>Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three formulations and API major, surface treatment chemical and Fortune brand stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\">Aurobindo Pharma<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,677.90<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">94,477<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.46<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.25%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.21<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/grauweil\/grauer-weil-india-ltd-share-price-today\">Grauer &amp; Weil (India)<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">79.04<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,540<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.60<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/awl\/adani-wilmar-ltd-share-price-today\">AWL Agri Business<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">190.54<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23,732<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.49<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P\/E multiples.<\/p>\n<p>Valuation matters here because formulations and API major, surface treatment chemical and Fortune brand stocks can look attractive on growth and still look expensive on earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Formulations and API major, surface treatment chemical and Fortune brand stocks have a strong roadmap in India because generic drug demand overseas, manufacturing output and branded staples keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Generic demand:<\/strong> Overseas markets buy affordable formulations and ingredients.<\/li>\n<li><strong>Manufacturing output:<\/strong> Factories use surface treatment chemicals.<\/li>\n<li><strong>Branded staples:<\/strong> Households choose packaged oils and foods.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Aurobindo_Pharma_Generic_Formulations_and_Ingredients_Build_the_Next_Leg\"><\/span><strong>Aurobindo Pharma: Generic Formulations and Ingredients Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aurobindo Pharma&#8217;s roadmap rests on generic formulations and active ingredients sold in the US, Europe and emerging markets, with a wide product basket supporting export revenue.<\/p>\n<p>Revenue grew from Rs 23,775.84 crore in FY22 to Rs 34,145.17 crore in FY26, a 43.6% rise, and FY26 revenue was 5.6% higher than FY25. FY26 net profit rose 0.6% to Rs 3,502.97 crore. Over four years, net profit rose from Rs 2,647.11 crore in FY22 to Rs 3,502.97 crore. In Q1 FY27, revenue grew 18.1% to Rs 9,414.58 crore, and net profit rose 25.2% to Rs 1,032.03 crore. Operating margin was 21.61% in FY26 and 23.10% in Q1 FY27 against 21.95% a year earlier.<\/p>\n<p>Debt to equity is 0.21 and return on equity is 9.25%. FY26 operating cash flow was Rs 5,526.37 crore against capital expenditure of Rs 3,104.67 crore. Aurobindo Pharma paid a dividend of Rs 4 per share for FY26, a yield of 0.25%. At a P\/E of 25.46 against an industry P\/E of 37.59, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Q1 FY27 operating margin was 23.10% against 21.61% for FY26, so margin stability is the figure to follow as volumes grow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Grauer_Weil_India_Surface_Treatment_Chemicals_Drive_the_Pipeline\"><\/span><strong>Grauer &amp; Weil (India): Surface Treatment Chemicals Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Grauer &amp; Weil&#8217;s roadmap rests on surface treatment chemicals and related industrial products, with several business lines supporting earnings.<\/p>\n<p>Revenue grew from Rs 782.11 crore in FY22 to Rs 1,239.78 crore in FY26, a 58.5% rise, and FY26 revenue was 5.1% higher than FY25. FY26 net profit rose 4.3% to Rs 164.03 crore. Over four years, net profit rose from Rs 78.77 crore in FY22 to Rs 164.03 crore. In Q1 FY27, revenue grew 17.0% to Rs 311.11 crore. Operating margin was 18.87% in FY26.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 15.16%. FY26 operating cash flow was Rs 151.86 crore against capital expenditure of Rs 53.65 crore. Grauer &amp; Weil paid a dividend of Rs 1 per share for FY26, a yield of 1.28%. At a P\/E of 22.12 against an industry P\/E of 36.60, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 22.12 against an industry P\/E of 36.60 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"AWL_Agri_Business_Edible_Oils_and_Staples_Build_the_Next_Leg\"><\/span><strong>AWL Agri Business: Edible Oils and Staples Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>AWL Agri&#8217;s roadmap rests on edible oils, packaged foods and staples sold under the Fortune brand, with a wide distribution network supporting volumes.<\/p>\n<p>Revenue grew from Rs 54,327.16 crore in FY22 to Rs 75,148.47 crore in FY26, a 38.3% rise, and FY26 revenue was 17.6% higher than FY25. FY26 net profit was Rs 990.44 crore. In Q1 FY27, revenue grew 16.5% to Rs 20,116.91 crore, and net profit rose 47.7% to Rs 351.39 crore. Operating margin was 3.38% in FY26 and 3.90% in Q1 FY27 against 3.39% a year earlier.<\/p>\n<p>Debt to equity is 0.11 and return on equity is 9.98%. FY26 operating cash flow was Rs 3,928.34 crore against capital expenditure of Rs 833.37 crore. AWL Agri paid a dividend of Rs 1 per share for FY26, a yield of 0.55%. At a P\/E of 20.49 against an industry P\/E of 34.85, the stock trades below its industry multiple.<\/p>\n<p>What to watch: Net profit margin is only 1.3%, so small cost changes move earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_in_India_Aurobindo_Pharma_vs_Grauer_Weil_vs_AWL_Agri_on_Key_Financials\"><\/span><strong>Best Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks in India: Aurobindo Pharma vs Grauer &amp; Weil vs AWL Agri on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best formulations and API major, surface treatment chemical and Fortune brand stocks in India, Aurobindo Pharma leads on FY26 operating margin and Q1 FY27 revenue growth; Grauer &amp; Weil leads on return on equity and the lowest debt to equity; AWL Agri leads on FY26 revenue growth and the lowest P\/E. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Aurobindo Pharma<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Grauer &amp; Weil<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">AWL Agri<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34,145.17<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,239.78<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">75,148.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,502.97<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">164.03<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">990.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.61%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.87%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.38%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.25%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.16%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.46<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.49<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.21<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.25%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.28%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.55%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,526.37<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">151.86<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,928.34<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen formulations and API major, surface treatment chemical and Fortune brand stocks and shortlist formulations and API major, surface treatment chemical and Fortune brand stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these formulations and API major, surface treatment chemical and Fortune brand stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\"><\/span><strong>Risks to Consider Before Investing in Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Aurobindo Pharma, Grauer &amp; Weil and AWL Agri live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare, chemicals and consumer stocks cover generics, surface chemicals and edible oils. Aurobindo Pharma leads on FY26 operating margin and Q1 FY27 revenue growth; Grauer &amp; Weil leads on return on equity and the lowest debt to equity; AWL Agri leads on FY26 revenue growth and the lowest P\/E.<\/p>\n<p>Across formulations and API major, surface treatment chemical and Fortune brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the formulations and API major, surface treatment chemical and Fortune brand stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Formulations_and_Api_Major_Surface_Treatment_Chemical_and_Fortune_Brand_Stocks\"><\/span><strong>FAQs on Formulations and Api Major, Surface Treatment Chemical and Fortune Brand Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best formulations and API major, surface treatment chemical and Fortune brand stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aurobindo Pharma, Grauer &amp; Weil (India) and AWL Agri Business stand out for their roadmaps in generics, surface chemicals and edible oils. FY26 revenue growth was 5.6% at Aurobindo Pharma, 5.1% at Grauer &amp; Weil and 17.6% at AWL Agri, and return on equity ranges from 9.25% to 15.16%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Aurobindo_Pharma_a_good_stock_to_buy_now\"><\/span><strong>Is Aurobindo Pharma a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aurobindo Pharma has a debt to equity ratio of 0.21, a return on equity of 9.25% and a P\/E of 25.46 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Aurobindo_Pharma_Grauer_Weil_and_AWL_Agri\"><\/span><strong>What is the P\/E ratio of Aurobindo Pharma, Grauer &amp; Weil and AWL Agri?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 25.46 for Aurobindo Pharma (industry 37.59), 22.12 for Grauer &amp; Weil (industry 36.60) and 20.49 for AWL Agri (industry 34.85). All of them trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these formulations and API major, surface treatment chemical and Fortune brand stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Grauer &amp; Weil (India) has the highest return on equity at 15.16%, followed by AWL Agri Business at 9.98% and Aurobindo Pharma at 9.25%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks\"><\/span><strong>What are the risks of investing in formulations and API major, surface treatment chemical and Fortune brand stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Aurobindo_Pharma_Grauer_Weil_and_AWL_Agri_perform_in_Q1_FY27\"><\/span><strong>How did Aurobindo Pharma, Grauer &amp; Weil and AWL Agri perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aurobindo Pharma reported revenue of Rs 9,414.58 crore, up 18.1% year on year, and net profit rose 25.2% to Rs 1,032.03 crore. Grauer &amp; Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_pay_dividends\"><\/span><strong>Do formulations and API major, surface treatment chemical and Fortune brand stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.25% for Aurobindo Pharma, 1.28% for Grauer &amp; Weil and 0.55% for AWL Agri, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_formulations_and_API_major_surface_treatment_chemical_and_Fortune_brand_stocks_in_India\"><\/span><strong>How can I invest in formulations and API major, surface treatment chemical and Fortune brand stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy formulations and API major, surface treatment chemical and Fortune brand stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best formulations and API major, surface treatment chemical and Fortune brand stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aurobindo Pharma, Grauer & Weil (India) and AWL Agri Business stand out for their roadmaps in generics, surface chemicals and edible oils. FY26 revenue growth was 5.6% at Aurobindo Pharma, 5.1% at Grauer & Weil and 17.6% at AWL Agri, and return on equity ranges from 9.25% to 15.16%.\"}},{\"@type\":\"Question\",\"name\":\"Is Aurobindo Pharma a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aurobindo Pharma has a debt to equity ratio of 0.21, a return on equity of 9.25% and a P\/E of 25.46 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Aurobindo Pharma, Grauer & Weil and AWL Agri?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 25.46 for Aurobindo Pharma (industry 37.59), 22.12 for Grauer & Weil (industry 36.60) and 20.49 for AWL Agri (industry 34.85). All of them trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these formulations and API major, surface treatment chemical and Fortune brand stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Grauer & Weil (India) has the highest return on equity at 15.16%, followed by AWL Agri Business at 9.98% and Aurobindo Pharma at 9.25%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in formulations and API major, surface treatment chemical and Fortune brand stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.\"}},{\"@type\":\"Question\",\"name\":\"How did Aurobindo Pharma, Grauer & Weil and AWL Agri perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aurobindo Pharma reported revenue of Rs 9,414.58 crore, up 18.1% year on year, and net profit rose 25.2% to Rs 1,032.03 crore. Grauer & Weil (India) reported revenue of Rs 311.11 crore, up 17.0% year on year. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do formulations and API major, surface treatment chemical and Fortune brand stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.25% for Aurobindo Pharma, 1.28% for Grauer & Weil and 0.55% for AWL Agri, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in formulations and API major, surface treatment chemical and Fortune brand stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy formulations and API major, surface treatment chemical and Fortune brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aurobindo Pharma, Grauer &#038; Weil (India) and AWL Agri Business compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":28,"featured_media":314021,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[10618,11210,12962,12963,12964],"class_list":["post-314023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-aurobindo-pharma","tag-awl-agri-business","tag-formulations-and-api-major","tag-surface-treatment-chemical-and-fortune-brand-stocks","tag-surface-treatment-chemical-and-fortune-brand-stocks-to-buy"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["314021"],"rank_math_title":["formulations major, surface chemical and edible oil stocks"],"rank_math_description":["Formulations and API major, surface treatment chemical and Fortune brand stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["formulations and API major, surface treatment chemical and Fortune brand stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-formulations-and-api-major-surface-treatment-chemical-and-fortune-brand-stocks.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/314023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=314023"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/314023\/revisions"}],"predecessor-version":[{"id":314024,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/314023\/revisions\/314024"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/314021"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=314023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=314023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=314023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}